BioRestorative Therapies, Inc. develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Our two core programs relate to the treatment of disc/spine disease and metabolic disorders.
Statements in this presentation, including the information set forth as to the future financial or operating performance of BioRestorative Therapies, Inc. (the “Company”), that are not current or historical factual statements may constitute “forward looking” information within the meaning of securities laws.
When used in this presentation, such statements may include, among other terms:
BioRestorative Therapies' combined Management Team, Board of Directors and Scientific Advisory Board members have extensive experience in the healthcare industry. Together we have expert experience in the stem cell science, medical-related services, life science services marketing, public company business management and financing, IP development and licensing, business acquisitions, and strategic partnering.
Chief Executive Officer, President and Chairman
Vice President of Operations and Corporate Secretary
Vice President of Research and Development and Chief Scientist
President of Disc/Spine Division
Vice President, Quality and Compliance